Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Maryline Bonnet

12 ta ish

Institute of Research for Development

AkademScholarda batafsil koʻrsatkichlar

  1. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study

    Elisabeth Sánchez-Padilla, Caroline Marquer, Stobdan Kalon +5

    Maqola20145 iqtibos
    ABI

  2. Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection

    Maryline Bonnet, Manuela Pardini, Francesca Meacci +14

    MaqolaOchiq kirish20114 iqtibos
    ABI

  3. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

    Sharh maqolaOchiq kirish20184 iqtibos
    ABI

  4. Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations

    Francis Varaine, Lorenzo Guglielmetti, Helena Huerga +5

    Boshqa20162 iqtibos
    ABI

  5. High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010

    Elisabeth Sánchez-Padilla, Themba Dlamini, Alexandra Ascorra +7

    MaqolaOchiq kirish20122 iqtibos
    ABI

  6. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

    Federica Fregonese, Shama D. Ahuja, Onno W. Akkerman +55

    Sharh maqola20182 iqtibos
    ABI

  7. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    BoshqaTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine20151 iqtibos
    ABI

  8. Does One Size Fit All? Drug Resistance and Standard Treatments: Results of Six Tuberculosis Programmes in Former Soviet Countries.

    Maryline Bonnet, Vinciane Sizaire, Yared Kebede +9

    Boshqa20050 iqtibos
    ABI

  9. Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)

    Maryline Bonnet, Mathieu Bastard, Philipp du Cros +7

    MaqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20130 iqtibos
    ABI

  10. A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients

    Cathy Hewison, Teshome Ashagre, Tigay Zinaida +7

    MaqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20130 iqtibos
    ABI

  11. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    BoshqaTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine20150 iqtibos
    ABI

  12. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

    Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyPLoS ONE20180 iqtibos
    ABI